EU pledges 200 million vaccine doses to low-income nations

Wednesday, September 15, 2021 | Raf Casert, Associated Press

EU Commission President von der Leyen speaks at European Parliament in Strasbourg
European Commission President Ursula von der Leyen applauds after delivering a State of the Union Address at the European Parliament in Strasbourg, France, Wednesday, Sept. 15, 2021. Stung by the swift collapse of the Afghan army and the chaotic U.S.-led evacuation through Kabul airport, the European Union on Wednesday unveiled new plans to develop its own defense capacities to try to ensure that it has more freedom to act in future crises. (Yves Herman, Pool via AP)

BRUSSELS (AP) — The European Union’s top official said Wednesday that ramping up COVID-19 vaccinations around the world was the bloc's No. 1 priority right now and committed another 200 million vaccine doses to Africa and low-income nations.

European Commission President Ursula von der Leyen used her State of the European Union speech on Wednesday to announce the new donation that will be fully delivered by the middle of next year and comes on top of 250 million vaccine doses already pledged.

Even when rich nations are already contemplating giving a third booster vaccine shot to large swathes of their populations, most of the world's poorer nations are still waiting to be fully vaccinated, laying bare an acute sense of vaccine inequality.

“Our first and most urgent priority is to speed up global vaccination," von der Leyen told European parliamentarians in a plenary left nearly empty because of continued virus regulations.

Von der Leyen said the bloc was also investing 1 billion euros ($1.2 billion) to boost increased vaccine production capacity in Africa.

African health officials say they need just under 800 million doses to vaccinate 60% of the continent’s population. As of last week, 145 million doses had been procured, according to the Africa Centers for Disease Control and Prevention.

Just 3.5% of people across the continent of 1.3 billion people have been fully vaccinated, the CDC says, amid frustrations over hoarding, vaccine export controls and now the rollout of booster shots in richer countries.

Reacting to von der Leyen’s announcement, Jagoda Munic, the director of Friends of the Earth Europe, said the EU should make COVID-19 vaccines and treatments a public good, accessible to everyone instead of relying on vaccine donations.

“We are witnessing a global vaccine apartheid,” she said. “People in the Global South least responsible for the climate crisis and least protected from it, are now being left unprotected from the pandemic. This compounding of injustice is at odds with European values and solidarity.”

Von der Leyen stressed that on top of delivering 700 million vaccine doses to Europeans, the 27-nation bloc had also sent as many shots to 130 nations.

“We are the only region in the world to achieve this,” she said. "With less than 1% of global doses administered to lower income countries, the scale of injustice and the level of urgency is obvious.”

Even though the EU had allowed vaccine exports even when its own population was still struggling to get enough doses, the challenge to get the world vaccinated remains immense.

“Let’s do everything possible to ensure that this does not turn into a pandemic of the unvaccinated,” she said.

The European Commission president did acknowledge that the bloc was initially caught unaware, lagging the U.S. and Britain in vaccination rates before regrouping and meeting its goal of having 70% of EU adults vaccinated this summer.

She lauded the preparations to set up the HERA emergency preparedness and response authority and insisted that academic science and private sector knowledge should be joined up with government authorities in a new group backed by 50 billion euros ($60 billion) in funding by 2027.


Sam Petrequin from Brussels and Cara Anna from Nairobi contributed to this report.


Follow AP’s pandemic coverage at:

7 Stocks That Can Withstand a Taper Tantrum

The stock market is stimulated like a child with a sugar high on Halloween night, and investors are enjoying the ride. It seems like nearly every sector continues to point in one direction. But seasoned investors know that the markets don’t move in the same direction all the time. And even long-term bulls admit that a correction may be coming.

One reason for this is that the Federal Reserve (i.e. “The Fed”) is “talking about, talking about” an end to its asset purchase program. If that talk turns into concrete action, then it would be almost a sure sign that interest rates will rise sooner than expected.

That combination is typically negative for equities, such as stocks. Yet, even if the Fed announces an earlier-than-expected tapering plan, there are stocks that will hold up well and even thrive. And that’s the focus of this presentation. We’re taking a looks at seven stocks that stand to benefit from a less accommodative monetary policy. Financial stocks are one group of stocks that will benefit from rising interest rates. And you should also consider stocks with a high return on equity (ROE).

ROE = Net Income/Shareholders’ Equity

Stocks with a high ROE are reinvesting cash at a high rate of return which can make them an ideal choice when that cash becomes more valuable.

View the "7 Stocks That Can Withstand a Taper Tantrum".

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.